Name (Synonyms) | Correlation | |
---|---|---|
drug159 | Aerosol-reducing Mask Wiki | 1.00 |
drug2682 | Standard Mask Wiki | 1.00 |
drug2122 | Placebo Wiki | 0.05 |
Name (Synonyms) | Correlation | |
---|---|---|
D055370 | Lung Injury NIH | 0.20 |
D055371 | Acute Lung Injury NIH | 0.10 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.09 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.08 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Study KIN-1901-2001 is a multi-center, adaptive, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of gimsilumab in subjects with lung injury or acute respiratory distress syndrome (ARDS) secondary to COVID-19.
Description: Subjects who die will be assigned "0" ventilator-free days
Measure: Number of ventilator-free days Time: Baseline to Day 29